ICIDCA’s General Director Mariela Gallardo told Prensa Latina this product will be used in the pharmaceutical industry.
That microcrystalline cellulose, a derivative of cellulose including sugarcane bagasse, is so useful as an excipient in the pharmaceutical industry and as a substitute for flour and sucrose in low-calorie foods.
Another ICIDCA’s achievement is the completion of a small plant to produce dextran for pharmaceutical purposes.
The entity considered unique of its kind in the sugar cane diversification world, has developed technologies for the production of alcohols, rums and spirits, raw and refined wax, bagasse boards, animal feed, energy, syrups, candies and bioproducts with various uses and edible mushrooms.
Experts agree that sugar cane can provide nearly a hundred different derivatives, and constitutes the crop with the greatest spectrum of diversification. In the 1980s, the country manufactured about 30 types of products derived from sugar cane.